Treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Treatment for hypertension, female was 59.4% in 2019. ▲ Rising
Treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries), 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of female adults ages 30-79 with hypertension.
Analysis
The most recent figure for treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries) is 59.4%, measured in 2019.
Compared with earlier readings it is down 0.3% on the previous year and up 1.4% over ten years.
Over the whole period, treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries) peaked at 59.9% in 2014 and was at its lowest, 32.3%, in 1990.
Europe & Central Asia (IDA & IBRD countries) ranks 11th of 43 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % of female adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 32.3% | — |
| 1991 | 33.7% | +4.4% |
| 1992 | 35.2% | +4.5% |
| 1993 | 36.7% | +4.3% |
| 1994 | 38.4% | +4.4% |
| 1995 | 40.0% | +4.3% |
| 1996 | 41.7% | +4.1% |
| 1997 | 43.3% | +3.8% |
| 1998 | 44.9% | +3.7% |
| 1999 | 46.4% | +3.5% |
| 2000 | 47.9% | +3.2% |
| 2001 | 49.4% | +3.1% |
| 2002 | 50.9% | +3.0% |
| 2003 | 52.3% | +2.8% |
| 2004 | 53.7% | +2.6% |
| 2005 | 55.0% | +2.4% |
| 2006 | 56.1% | +2.1% |
| 2007 | 57.1% | +1.7% |
| 2008 | 57.9% | +1.4% |
| 2009 | 58.5% | +1.1% |
| 2010 | 59.1% | +0.9% |
| 2011 | 59.5% | +0.7% |
| 2012 | 59.7% | +0.5% |
| 2013 | 59.9% | +0.2% |
| 2014 | 59.9% | +0.1% |
| 2015 | 59.9% | -0.0% |
| 2016 | 59.8% | -0.1% |
| 2017 | 59.6% | -0.3% |
| 2018 | 59.5% | -0.2% |
| 2019 | 59.4% | -0.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 39.3% | 32.3% | 46.4% | 10 |
| 2000s | 53.9% | 47.9% | 58.5% | 10 |
| 2010s | 59.6% | 59.1% | 59.9% | 10 |
Countries ranked near Europe & Central Asia (IDA & IBRD countries)
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 25-29, male, per capita 0.0307 units per person (2025)
Frequently asked questions
- What is treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries)?
- Treatment for hypertension, female in Europe & Central Asia (IDA & IBRD countries) was 59.4% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, female recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 59.9% in 2014.
- What is the lowest treatment for hypertension, female recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 32.3% in 1990.
- How does Europe & Central Asia (IDA & IBRD countries) rank for treatment for hypertension, female?
- Europe & Central Asia (IDA & IBRD countries) ranks 11th out of 43 groups with data for 2019.
- Is treatment for hypertension, female rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is up 1.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.